tirzepatide weight loss before and after men Look at our awesome client's progress Before and After photos on Weight loss progress with tirzepatide

The strategy for the management of type 2 diabetes was updated in 2018 in response to the abundance of new cardiovascular outcome data from the CVOTs published since 2015, which showed safety, tolerability, and cardiovascular and renoprotection with 2 classes of agents, sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide receptor agonists (GLP1RA) in patients with established CVD (11)

The SURMOUNT-4 trial showed that participants who stopped tirzepatide regained most of their lost weight within a year, while those who continued maintained their weight loss

This combination not only helps you lose weight but may also support your energy, focus, and overall well-being

2020 Nov 5;80(3):485-500